Video Endoscopy Systems

Canon Medical Components U.S.A., Inc. is a healthcare technology supplier specializing in digital radiography systems and advanced medical imaging components. The company manufactures the Canon CXDI Wireless Digital Radiography Systems, a current-generation platform for clinical X-ray imaging in healthcare facilities. Canon Medical Components also develops and supplies video sensing devices, including ultra-HD and high-definition medical video cameras with chip-on-tip configurations for endoscopic and intra-operative visualization applications. Additionally, the company manufactures key diagnostic components through its Canon Electron Tube & Devices division, supplying critical elements for clinical diagnostic equipment and industrial inspection systems. The company serves U.S. healthcare facilities including hospitals, diagnostic centers, and surgical environments. Canon Medical Components operates as a division of Canon Inc., leveraging global imaging and optical expertise to deliver regulated medical-grade equipment and components compliant with healthcare standards.

Stryker Corporation is a global medical technology company headquartered in Portage, Michigan, serving hospitals, surgical centers, and healthcare providers worldwide. The company manufactures and distributes a comprehensive portfolio of medical devices, surgical equipment, implants, and visualization systems across multiple specialties including orthopedics, neurosurgery, spine, trauma, cardiovascular, endoscopy, acute care, and emergency medicine. Key product categories include joint replacement implants (hips, knees) with Mako Robotic-Arm Assisted Technology, neurosurgical and spine instruments with 3D-printed technologies, minimally invasive surgical systems (laparoscopy, arthroscopy, endoscopy), emergency care equipment, communications systems for patient environments, interventional spine products (vertebroplasty, radiofrequency ablation), craniomaxillofacial solutions, sports medicine implants, and neurovascular stroke care devices. Stryker operates manufacturing facilities in multiple countries including Canada, China, and the US. The company maintains a strong commitment to sustainability through device reprocessing and remanufacturing services for single-use medical devices. With regional headquarters and distribution centers across the Americas, Europe, Asia-Pacific, and Middle East & Africa, Stryker provides integrated sales, service, and technical support. The company is regulated by the FDA and maintains global certifications for medical device manufacturing and quality management systems.

Optim LLC manufactures endoscopic visualization equipment for ENT (ear, nose, throat) and functional endoscopic evaluation of swallowing (FEES) applications, along with security and industrial inspection systems. The company specializes in portable, high-quality endoscopic instruments designed for clinical use in otolaryngology and speech-language pathology practices. Primary product lines include the ENTity XL/SDXL rigid endoscopic system, the ENTity MobileFEES portable platform, flexible nasopharyngoscopes (ENT 3.6FP), rigid sinuscopes, and complementary accessories such as portable LED light sources (PLS) and USB video capture systems (VidCap). The company also manufactures security and industrial visualization equipment including the FreedomView videoscope and fiberscope systems. Optim operates a contract design and manufacturing division offering medical device design and manufacturing expertise. The company emphasizes durability, optical clarity, portability, and submersibility for complete disinfection. Manufacturing capabilities include fused fiber optics, precision optical components, and light source coupling. The company provides comprehensive customer support including service and repair, care and maintenance guidance, in-service training, and product registration programs. Optim holds GSA contract capabilities and serves healthcare providers across the United States. The company is based in Sturbridge, Massachusetts, and employs a leadership team with extensive experience in medical device manufacturing, quality assurance, optical engineering, and ENT sales.

MediCapture Inc. is a medical equipment manufacturer specializing in portable and robust video recording and archiving systems for surgical and medical imaging applications. Founded in 2002 and headquartered in Plymouth Meeting, Pennsylvania, the company has deployed over 50,000 units across 80+ countries. MediCapture's core offerings include Full HD and 4K digital video recording systems compatible with various surgical cameras, including the iMave Pro platform, MVR series recorders (MVR436, MVR460), and the new MTR series. The company provides seamless integration with Hospital Information Systems via its Smart Workflow software, enabling capture of endoscopy, gastroenterology, ophthalmic, laparoscopic, and general surgical procedures. MediCapture emphasizes high reliability, network integration, customizable solutions, and local service support for operating room teams and healthcare professionals worldwide.

SourceMark Medical is a healthcare product innovation, manufacturing, and distribution company founded in 2002 and based in Franklin, Tennessee. As a certified Minority Business Enterprise, SourceMark specializes in bringing affordable, clinically-reviewed medical and surgical solutions to market through its integrated commercialization and distribution platform. The company bridges operational and clinical gaps for safety-net hospitals, group purchasing organizations (GPOs), integrated delivery networks, and other healthcare providers by developing and scaling innovative products across four core categories: anesthesia and airway management, infection prevention, surgical products, and fire and EMS solutions. SourceMark operates the Alliance Program, which supports healthcare entrepreneurs and manufacturers in scaling products from concept through prototype development, licensing, launch, and large-scale adoption. The company partners with major distributors and GPOs including HealthTrust, Premier, Vizient, Cardinal Health, McKesson, Concordance, Owens & Minor, and Medline to ensure broad market access. SourceMark's product portfolio emphasizes clinician engagement and patient outcomes through innovative approaches to airway management, surgical instrumentation, and infection control.

Q3 Medical USA, LLC is a subsidiary of Q3 Medical Group, an Irish medical device holding company specializing in the development, manufacturing, and global distribution of innovative minimally invasive and biodegradable medical devices. The company focuses on cardiology, peripheral vascular, and non-vascular applications, with particular expertise in biodegradable implants, micro-invasive technologies, and drug delivery platforms. Q3 Medical's flagship product, ARCHIMEDES, is the first fully biodegradable biliary and pancreatic stent, designed to eliminate the need for removal procedures while reducing complications and healthcare costs. Operating through subsidiaries in Germany, China, and the USA, the company employs a clinician-led, multidisciplinary approach to develop patient-centric solutions that streamline treatment pathways, reduce hospital stays, and lower overall healthcare expenses. The company is committed to advancing sustainable healthcare through innovative technologies that balance superior patient outcomes with economic and environmental benefits.

HJY Smart Medical Device Co., Ltd. (HJY Forward Medical Investment) is a Taiwan-based medical device manufacturer specializing in minimally invasive endoscopic surgery solutions and AI-assisted surgical technologies. Established in 2019, the company develops and manufactures innovative endoscopic vision systems addressing unmet needs in neuro- and orthopedic surgery. HJY's product portfolio includes FDA-approved VisualNext® 2D endoscopic vision systems for diagnostic and surgical applications, next-generation 3D head-mounted display (HMD) technology for real-time surgical visualization, and the HJY-YESS posterior lumbar retractor system for spine surgery. The company operates subsidiaries across China and the USA, positioning itself as a leader in next-generation endoscopy medtech with a focus on AI-integrated surgical platforms. HJY combines hardware innovation with artificial intelligence to advance minimally invasive surgical techniques.

Medtronic is a global healthcare technology leader serving 79+ million patients across diagnostic imaging, surgical and operating room equipment, intensive care, specialty medical, and homecare sectors. The company manufactures and distributes a comprehensive portfolio spanning cardiac rhythm and diagnostics systems, pacemakers, implantable cardioverter-defibrillators, deep brain stimulation devices, robotic surgery platforms, ventilators, anesthesia machines, infusion pumps, continuous glucose monitoring systems, insulin pumps, endoscopic and surgical navigation systems, and wound closure products. Recent FDA clearances include the Stealth AXiS surgical system for spine surgery and pulsed field ablation (PFA) technologies for atrial fibrillation treatment. Medtronic serves hospitals, surgical centers, critical care units, interventional labs, and home care settings through product lines in cardiac, vascular, neuromodulation, minimally invasive surgery, respiratory, and diabetes management. The company conducts 170+ active clinical trials, invests $2.7B annually in R&D, and holds FDA 510(k) clearances, CE marks, and ISO 13485 certification. Manufacturing and distribution capabilities span North America, Europe, and international markets with customer support available 24/7.

LEADOPTIK Inc. is a deep-tech medical device startup founded in 2020 and based in San Jose, California. The company specializes in advanced pulmonary imaging and biopsy technology for early-stage lung cancer detection. LEADOPTIK develops miniature optical probes utilizing its proprietary Last Inch Assessment™ (LIA™) Technology, which delivers high-resolution, real-time 3D microstructure imaging in ultra-thin formats. This innovation enables access to narrow lung airways that conventional bronchoscopes cannot reach, addressing a critical clinical gap in interventional pulmonology. The LIA™ Technology employs dielectric metasurfaces and nanofabrication techniques to achieve unprecedented precision in nodule assessment and biopsy guidance, reducing diagnostic uncertainty and improving patient outcomes. The company is backed by $5.25 million in funding and supported by leading venture capital partners including SOSV, Sony Innovation Fund, and Meta Venture Partners. LEADOPTIK's clinical advisory board includes pulmonologists from major academic medical centers, and the company is preparing for FDA submission.

NovaProbe Inc. is a US-based manufacturer of surgical products specifically designed for endoscopic procedures, with a primary focus on laparoscopic surgery. All products are FDA-registered and CE-approved. The company specializes in surgical visualization equipment and accessories, including control panels with embedded 4K touch interfaces and HD/4K visualization systems. NovaProbe serves surgeons and gynecologists globally, offering high-quality, affordable devices informed by industry-leading surgical feedback. The company maintains dedicated divisions for medical device manufacturing (R&D), regulatory compliance consulting, and process automation controls for pharmaceutical and chemical industries.

EndoSound, Inc. is a medical device manufacturer specializing in affordable endoscopic ultrasound (EUS) systems. Founded in 2016 by gastroenterologist Stephen Steinberg, M.D., and bioengineer Scott Corbett, the Portland, Oregon-based company has developed a patented plug-and-play device that converts standard flexible upper endoscopes into EUS systems. The EndoSound system combines endoscopy and ultrasound imaging to enable diagnosis and treatment of pancreatic cancer and other digestive tract disorders. The solution is designed for GI labs, hospitals, clinics, and ambulatory surgery centers, offering significant cost savings and accessibility advantages compared to dedicated big-box EUS systems from competitors like Pentax, Olympus, and Fujifilm. The company is focused on expanding global access to EUS technology, particularly in underserved regions and Latin America.

Anatomage Inc. is a leader in advanced 3D medical virtualization technology founded in 2004. The company specializes in digitizing real human cadavers into interactive, fully functional 3D anatomical models called Anatomage Bodies, which provide ultra-high-definition, life-size representations of human anatomy, physiology, and pathology. Anatomage's flagship product, the Anatomage Table, is a life-size virtual dissection platform used for medical education, surgical planning, and clinical diagnosis. The company also offers complementary software solutions including Invivo5 for radiology and cloud-based learning platforms. With products deployed across 4,000+ healthcare and educational institutions in over 20 countries, Anatomage supports anatomy education, clinical training, surgical planning, and medical research. The platform enables visualization of anatomical variations, real-time physiological simulations, and practice of clinical procedures on digitized cadavers, significantly reducing medical errors and enhancing educational outcomes.

Tangent Endoscopy manufactures the Tangent Digital Catheter System, a single-use flexible endoscope designed for choledochoscopy and biliary duct exploration (CBDE). The system features a 3.28mm outer diameter with a 1.6mm working channel—33% larger than competing systems—enabling enhanced procedural access and stone removal. The catheter delivers 400x400px digital vision with a 120° field of view, supporting both image capture and video via USB. The ambidextrous handle employs an intuitive lever-and-wheel mechanism for 4-axis control. The integrated digital controller offers HDMI outputs, adjustable brightness, and plug-and-play connectivity. FDA 510(k) cleared as of September 2025, the system is positioned for interventional endoscopy and advanced biliary interventions in hospital and specialty centers.

Visionix USA, part of the global Visionix group headquartered in Lombard, Illinois, specializes in intelligent diagnostic, screening, refraction, and lens finishing equipment for eye care professionals across North America. Founded in 1994 by Marc Abitbol, Ph.D., the company operates with 700 employees across 120 countries and has consolidated multiple brands (Briot, Weco, Optovue) into a unified portfolio. Visionix provides comprehensive solutions for opticians, optometrists, and ophthalmologists, including wavefront-based automated refraction systems (Eye Refract), high-speed OCT and OCTA imaging platforms (Optovue Solix), anterior and posterior segment screening devices (VX 650), and advanced lens finishing equipment. The company also delivers sales, service, technical training, and clinical education to enhance patient care accessibility and practice efficiency. As of April 2026, Visionix is merging with Revenio Group to expand its technological capabilities and market reach.

INVAMED is a Turkish medical device manufacturer headquartered in Ankara, founded in 2005, with operations spanning 15,000 m² and over 200 specialist employees. The company manufactures over 150 CE-marked medical devices across 23 product categories, exported to more than 80 countries with over 100 international patents. INVAMED specializes in cardiovascular and neurovascular interventional devices including coronary stents (ATLAS drug-eluting platform), mechanical thrombectomy systems (Mantis platform), and embolization devices (MultiBEAM vascular plugs, Spider coils, LIBRO EVOH liquid embolic agent). The company also produces comprehensive orthopedic implant solutions (CytroFIX system with intramedullary nails and locking plates), varicose vein treatment systems (VenaBLOCK, ThermoBLOCK, LaserBLOCK), aortic stent grafts (STENA MFM), and specialty devices for urology, ENT, pain management, dental implants (DENTURA), and digital health monitoring (RhythmTrack cardiac telemetry). All products comply with EU MDR 2017/745 and ISO 13485 standards. INVAMED maintains an in-house R&D center (INVAcenter) with 40+ biomedical engineers and has delivered over 500,000 device units since 2010.

Creo Medical is a UK-based medical device manufacturer specializing in minimally invasive electrosurgical instruments for therapeutic endoscopy. Founded in 2001 and headquartered in Chepstow, Wales, the company designs and markets advanced energy devices utilizing proprietary Kamaptive® Technology, which combines high-frequency microwave and bipolar radiofrequency energy. The product portfolio spans gastroenterology, urology, and pulmonology applications, featuring flagship devices such as the Speedboat Inject (resection), MicroBlate ablation systems, and specialized endoscopic accessories. Creo Medical holds 318 patents globally and operates 14 offices across nine countries. The company has achieved FDA and CE Mark regulatory clearances and demonstrates strong clinical adoption, including NHS supply chain qualification with documented cost savings (£687k over 12 months in pilot programs). The product range encompasses diagnostic tools (biopsy forceps, capsule endoscopy systems), therapeutic instruments (polypectomy snares, extraction devices, hemoclips), and hygiene components for endoscope maintenance.

IntroMedic Co., Ltd. is a South Korean medical technology company founded in 2004, specializing in capsule endoscopy systems and minimally invasive endoscopic diagnostic equipment. The company manufactures and markets the MiroCam® Capsule Endoscope System for high-resolution gastrointestinal imaging, the E.G. Scan™ flexible video esophagoscope for esophageal and gastric visualization, and EndoClot hemostasis equipment for bleeding control. IntroMedic holds ISO 13485 certification and FDA 510(k) clearance, serving hospitals and clinics globally with approximately 70 employees. The company is committed to advancing minimally invasive endoscopy solutions for improved diagnostic accuracy and patient outcomes in gastroenterology and related specialties.

ECOTRON Co., Ltd. is a South Korean medical imaging equipment manufacturer specializing in X-ray systems and diagnostic imaging solutions. The company designs and manufactures a comprehensive portfolio of radiography systems, portable X-ray devices, surgical imaging systems, dental imaging equipment, and X-ray generators. ECOTRON also develops AI-based diagnostic solutions and specialized medical imaging devices for urology applications. The product range extends to veterinary X-ray systems and offers OEM/ODM manufacturing services for medical device partners. The company positions itself as a leader in advanced X-ray technology and sustainable medical solutions, with a commitment to innovation and customer support through exhibitions, technical inquiries, and comprehensive customer service channels.

FUJIFILM Healthcare Americas Corporation is a leading provider of diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, and in vitro diagnostics solutions. With nearly 90 years of medical imaging heritage since 1936, the company delivers comprehensive healthcare technology portfolios spanning prevention, diagnosis, and treatment. Key offerings include the Synapse® Enterprise Imaging platform for clinical workflow optimization, advanced diagnostic imaging systems, endoscopy device and imaging technology portfolios, surgical imaging solutions, and serum biomarker assays for liver cancer screening. The company serves healthcare organizations across the care continuum, providing integrated solutions that support clinicians, administrators, and patients through tailored user experiences and clinical decision support capabilities.

Lumicell, Inc. is a medical technology company founded in 2009 as a spinout from MIT that specializes in fluorescence-guided imaging systems for intraoperative tumor detection and resection. The company's core platform, LumiSystem, combines LUMISIGHT (a fluorescent optical contrast agent) with the Lumicell Direct Visualization System (DVS), a handheld real-time imaging device for surgical guidance. In April 2024, both LUMISIGHT and DVS received FDA approval as the first drug-device combination approved in over a decade for this indication. The technology is designed to help surgeons identify and remove residual cancer tissue while preserving healthy tissue during breast cancer lumpectomies and other oncologic procedures. Lumicell has validated its approach in clinical studies involving over 700 breast cancer patients and is expanding applications to solid tumors including gastric and gastrointestinal cancers.

CellTivity Scientific is a medical technology company specializing in live-cell imaging platforms for real-time assessment of cellular behavior, morphology, and metabolic activity. The flagship Van Gogh Microscopy System utilizes proprietary Dynamic Cell Imaging (DCI) technology to provide non-invasive visualization of metabolic activity and tissue adequacy during biopsies. The system enables proceduralists to identify cell types—including cancer cells, immune cells, and granuloma—and assess biopsy sample quality in real time, improving diagnostic yield and reducing biopsy inadequacy. Applications span interventional pulmonology, thoracic procedures, bronchoscopy, and general tissue sampling across oncology specialties. The company offers CE-registered devices with deployment, training, and pathology integration support to hospitals and clinics, targeting enhanced point-of-care diagnostics and streamlined collaboration with pathology departments.

Nventric is a contract development and manufacturing organization (CDMO) specializing in end-to-end medical device design, development, and manufacturing for the neurovascular, electrophysiology, and coronary markets. The company serves as a strategic partner to medical device OEMs, providing comprehensive solutions from concept through volume production. Nventric's capabilities span innovative design services, advanced prototyping, rigorous testing, clinical design inputs, and full manufacturing support with ISO 13485 certification. The company develops a broad range of interventional devices including revascularization devices, catheters (balloon, guide, aspiration, diagnostic, and ablation), drug-eluting stents, hemostasis valves, and peripherally inserted central catheters (PICCs). Nventric's focus on complex vascular anatomy navigation and energy delivery systems positions it as a specialized partner for treating vascular diseases across multiple clinical applications.

EndoClot Plus Co., Ltd. is a medical device manufacturer specializing in hemostatic solutions for gastrointestinal endoscopy. Based in Santa Clara, California with manufacturing operations in Suzhou Industrial Park, China, the company develops proprietary polysaccharide-based hemostatic systems designed to control bleeding during endoscopic procedures. Their flagship EndoClot® Polysaccharide Hemostatic System (PHS) delivers a biocompatible powder directly to GI tract wounds during endoscopy, enabling rapid hemostasis without thermal or mechanical trauma. The company collaborates with endoscopists and biomaterial scientists to advance therapeutic solutions for GI professionals, offering a pipeline of biomaterial-based devices including adhesive formulations and submucosal injection systems for endoscopic applications.

ZEISS Group is a leading German multinational optical and optoelectronics company founded in 1846, headquartered in Oberkochen with approximately 30 production and 25 development sites across nearly 50 countries. The company specializes in precision optics, optical systems, and advanced medical technologies. In medical technology, ZEISS manufactures diagnostic imaging systems, surgical microscopes, and ophthalmic devices including diagnostic systems and intraocular lenses through Carl Zeiss Meditec AG. Its research microscopy division develops optical, electron, and ion microscopes for life sciences and materials research. ZEISS also supplies semiconductor manufacturing equipment and industrial metrology solutions. The company demonstrates expertise in AI-enhanced imaging, digital health solutions, and innovation across healthcare, industrial, and research sectors. With consolidated earnings of approximately €2 billion annually, ZEISS maintains a commitment to precision engineering and technological advancement across multiple high-value markets.

Femasys Inc. is a woman-founded and led biomedical company dedicated to enhancing women's healthcare through innovative, minimally invasive, non-surgical technologies. The company focuses on addressing significant needs in infertility, contraception, and cancer diagnostics. With a mission to provide safe and accessible solutions, Femasys aims to improve patient care and health standards globally, supported by a robust portfolio of approximately 200 patents. The company develops a range of therapeutic and diagnostic products using a proprietary non-surgical delivery platform. Key offerings include FemaSeed, an intratubal insemination device; FemVue, an ultrasound-based diagnostic tool; FemBloc, a candidate for non-surgical birth control; and FemCerv, a tissue sampler for cervical cancer diagnosis. Femasys emphasizes safety and efficiency in its in-office approaches, with a commitment to empowering women throughout their reproductive journeys. The company is publicly traded on NASDAQ under the ticker FEMY.

MedGyn Products, Inc. is a leading B2B medical device manufacturer and distributor specializing in obstetric and gynecological equipment, instruments, and disposables for OB/GYN professionals worldwide. Based in Westmont, Illinois, with over 50 years of experience, the company offers a comprehensive product portfolio addressing family planning, general gynecology, gynecology/oncology, infertility, obstetrics, and urogynecology. Key product lines include digital video colposcopes (AL-106 HD), thermal ablation systems (MTA-100) for cervical cancer therapy, cryotherapy systems, pessaries for pelvic organ prolapse management, endometrial sampling devices (Endosampler™), and disposable colposcopy kits. MedGyn manufactures surgical instruments, electrosurgical generators, and endocervical sampling tools. The company maintains a strong commitment to cervical cancer prevention, maternal health innovation, and women's health equity, with extensive international distribution and recognition for excellence in product design and clinical performance.

Vathin Medical Instrument Co., Ltd. (also operating as Huaxin Medical) is a leading global manufacturer of disposable electronic endoscopes and minimally invasive surgical instruments. Founded in 2018 and headquartered in Xiangtan, Hunan Province, the company employs over 300 personnel with R&D and sales centers in Berlin and Shanghai. Vathin specializes in innovative disposable endoscope technologies across pulmonology, urology, otolaryngology, and gastroenterology, featuring proprietary riveted snake-bone designs enabling superior articulation (up to 210° bending angles) and precision positioning. The company operates an automated manufacturing facility producing 400,000 units annually with ISO certifications and over 200 patent applications. Vathin products are FDA and CE approved, distributed across 160+ countries, and marketed through strategic partnerships including Olympus. Product portfolio encompasses disposable bronchoscopes, cystoscopes, ureteroscopes, rhinolaryngoscopes, and complementary minimally invasive surgical instruments including laparoscopic staplers and ultrasonic energy devices. The company addresses clinical demand for infection-free, cost-effective alternatives to reusable instruments while supporting graded diagnosis and treatment protocols.

SmartSurgN Inc. is a Silicon Valley-based medical technology company specializing in advanced surgical visualization systems and fluid management devices. The company manufactures the SmartSurgN 4K ICG Visualization System, a high-resolution surgical imaging platform offering four imaging modalities (one visible mode and three fluorescence overlays) for precise visualization of vessels, blood flow, and tissue perfusion during minimally invasive procedures. Additionally, SmartSurgN produces the AirSurgN™ 50L Insufflator, a compact and lightweight gas management device with integrated smoke evacuation for enhanced operative clarity during electrosurgery. The company also designs custom rigid endoscopic scopes optimized for infrared imaging compatibility and system integration. Built on expertise in photonics, mechanronics, and embedded software, SmartSurgN's products are engineered to simplify complex surgical workflows through intuitive controls, seamless integration, and uncompromising image quality. The company has achieved FDA Pre-Market Clearance and ISO certification.

SYNERGY Medical is a comprehensive medical imaging, equipment, and supply distributor serving hospitals, health systems, ambulatory surgery centers, clinics, and government facilities across the United States and internationally. The company specializes in OR integration systems, surgical and diagnostic displays, surgical lighting solutions, medical video recording and imaging systems, and equipment booms. With a distribution network exceeding 50,000 products from nationally recognized manufacturers including Eizo, Barco, JVC, Sony, NDS Surgical Imaging, Bovie, AMICO, and Simeon Medical, SYNERGY partners closely with vendors to deliver high-quality solutions that reduce costs and improve operational efficiency. Core product categories include 4K surgical monitors, LED surgical lighting systems, diagnostic monitoring displays, video integration systems, surgical cameras, medical booms, suspension arms, electrosurgical equipment, and wireless imaging solutions. The company serves clinical engineering, radiology, purchasing, and supply chain decision-makers across institutional and government healthcare settings.

Rocoto is a wireless video solutions company specializing in zero-latency wireless video transmission systems for medical and industrial environments. Formed from the expertise of Amimon and Teradek Medical, the company combines over 20 years of innovation in video, RF, and networking technology. Rocoto delivers high-quality wireless video systems tailored for operating rooms, endoscopy, microscopy, and robotic surgery applications. The product portfolio includes the MD62 (ultimate OR wireless video system), SL11 (4K wireless camera), MD11 (wireless HDMI for operating rooms), and Connex Tower (4K industrial camera). All systems feature 1ms latency, 4K resolution capability, robust wireless links, and are designed for seamless integration into existing clinical workflows with minimal installation complexity.

Xenocor is a medical device company specializing in single-use, fog-free laparoscopic technologies for minimally invasive abdominal and thoracic surgeries. Founded in 2016 and based in Salt Lake City, Utah, Xenocor manufactures the Saberscope™ HD and Xenoscope—fully disposable 1080p HD laparoscopes with integrated LED lighting designed to eliminate common procedural challenges. The Saberscope™ HD features true 1080p HD imaging in a single-use format, articulates 90°, maintains thermal safety limits, and integrates camera, light source, and recording functionality into one compact device. These fog-free systems reduce cross-contamination risk, eliminate costly equipment reprocessing delays, and provide cost-effective alternatives to traditional capital-intensive laparoscopic systems, making advanced surgical visualization accessible to diverse healthcare facilities worldwide.

Bracco is a global leader in diagnostic imaging established in 1927 in Milan, Italy, with operations in over 100 countries and approximately €2.0 billion in annual revenue. The company operates three main business units: Bracco Imaging, ACIST Medical Systems, and Centro Diagnostico Italiano (CDI). Bracco specializes in contrast agents and imaging solutions for diagnostic radiology, including gadolinium-based contrast agents for MRI, iodamide and iopamidol for X-ray and CT imaging, barium-based products for radiography, and sulfur hexafluoride microbubbles for ultrasound applications. The company manufactures automated injection systems and advanced medical devices for cardiovascular imaging through its ACIST subsidiary, offering solutions in interventional cardiology. Bracco also develops specialized imaging technologies in nuclear oncology and fluorescence image-guided surgery. With 11 innovation centers worldwide and 8% of turnover reinvested in R&D, the company maintains over 2,500 active patents and is recognized for commitment to research, sustainability, and clinical excellence across diagnostic imaging modalities.

Remidio Innovative Solutions is a Bengaluru-based medical device manufacturer specializing in AI-enabled portable ophthalmic imaging solutions for early disease detection and screening. Founded in 2009, the company develops handheld fundus cameras, digital slit lamps, and autorefractors designed for retinal and anterior segment imaging in resource-constrained and point-of-care settings. Remidio's product portfolio enables diabetic retinopathy screening, glaucoma detection, age-related macular degeneration assessment, and emergency eye triage across primary care, home care, rural clinics, and emergency departments. The company's solutions integrate with teleophthalmology workflows and cloud-based image management platforms for remote specialist review. Beyond product manufacturing, Remidio operates a CDMO division providing end-to-end contract development and manufacturing services including design, engineering, regulatory guidance, and quality assurance for medical device startups and established firms. ISO 13485 and FDA-compliant, Remidio exports to over 20 countries and has demonstrated clinical validation across multiple peer-reviewed publications.

Galvanize Therapeutics is a medical device company specializing in Pulsed Electric Field (PEF) energy-based systems for therapeutic interventions. Following the 2023 merger of Gala Therapeutics, Galvanize Therapeutics, and Galaxy Medical, the company now operates the Aliya® PEF System platform. The company develops disease-modifying bronchoscopic and interventional therapies targeting chronic bronchitis, non-small cell lung cancer, metastatic solid tumors, and cardiac arrhythmias. The Aliya® system utilizes non-thermal pulsed electric fields to ablate tissue and modulate biologic processes, with recent clinical data demonstrating local tumor control and potential immune response induction in lung cancer patients. The company also previously developed the RheOx™ Bronchial Rheoplasty System for reducing mucus-producing cells in chronic bronchitis. Galvanize serves interventional pulmonologists, thoracic surgeons, and oncologists, with focus on minimally invasive, energy-based therapeutic delivery.

Lazurite Inc. manufactures wireless and cordless surgical visualization systems for the operating room and endoscopy clinic. The company's primary product is ArthroFree, a wireless arthroscopic camera system that eliminates traditional cords and light source boxes, improving OR efficiency and clinical workflow. The ArthroFree 2 system features a 1080p HD camera with on-board Meridiem image enhancement delivering 3x more light, paired with encrypted ultra-wide band wireless transmission technology. The camera utilizes sterilizable batteries with 60-minute runtime and a 5-bay charger supporting high case volume. Meridiem image enhancement software provides surgeons with real-time clarity and sharpness adjustment controls optimized for each surgical scenario. For endoscopy clinic settings, Lazurite offers ArthroFree cordless systems that reduce setup complexity and workflow disruptions. The company also manufactures the Sterlink Mini tabletop plasma sterilizer, specifically designed for point-of-care sterilization of endoscopic cameras, scopes, and batteries in 18 minutes using eco-friendly technology. Products are marketed to orthopedic, arthroscopic, and ENT surgical teams. Lazurite has published clinical literature demonstrating improved OR efficiency, reduced setup/takedown times, and cost-per-case benefits compared to traditional wired systems. Documentation includes Instructions for Use, sterilization protocols, and clinician testimonials from major health systems. The company emphasizes minimally invasive surgical safety and workflow optimization.

CellSolutions LLC manufactures comprehensive liquid-based cytology platforms for clinical and research laboratories. The company specializes in sample collection, preservation, automated slide preparation, and digital image analysis solutions—primarily for gynecological and non-gynecological cytology applications. Product portfolio includes the CellSolutions 30 and F50 automated processors, the BestCyte digital imaging and screening system, the GluCyte manual preparation method, and proprietary preservative fluids. BestCyte delivers high-resolution whole-slide imaging with remote diagnostic capability, networked virtual slide storage, and AI-driven cell grouping and detection algorithms. All systems support HPV and molecular testing compatibility. The platform is designed for mid-sized labs and clinical settings requiring walk-away automation, specimen adequacy improvement, and efficient case management.

Terason, a division of Teratech Corporation, is a global leader in portable ultrasound imaging systems founded in 1994. Based in Burlington, Massachusetts, Terason pioneered the first patented color portable ultrasound and specializes in ultrasound-guided venous intervention. The company's uSmart platform delivers high-performance micro-miniaturized ultrasound systems designed for diverse clinical settings including hospitals, outpatient centers, and point-of-care environments. Key product lines include the uSmart 3300 NexGen and uSmart 3200T NexGen systems, both recognized for superior image quality and reliability across multiple medical specialties. Terason's technology portfolio features advanced capabilities such as Enhanced Needle Visualization (ENV), TeraVision II imaging, TeraScape panoramic imaging, Smart Gestures control, capacitive touch interfaces, and open architecture integration with DICOM standards. The company emphasizes comprehensive clinical education and real-time technical support through its uConnect service, alongside partnerships with major organizations like Siemens and Brainlab.

Noah Medical is a medical device company specializing in robotic-assisted bronchoscopy systems. The company manufactures the Galaxy System, an intelligent robotic platform designed for pulmonary diagnostics and interventional procedures in the airway. The Galaxy System integrates advanced imaging, precision targeting, and adaptive workflow capabilities to enable minimally invasive navigation and sampling of lung lesions. Key features include real-time lesion localization, integrated digital tomosynthesis and augmented fluoroscopy imaging, and tool-in-lesion (TiLT+) technology for enhanced diagnostic confidence and workflow efficiency. The system targets interventional pulmonologists, thoracic surgeons, and hospital-based endoscopy/interventional suites. Clinical evidence demonstrates 96.7% diagnostic yield in lesion localization (Match 2 Study, 31-patient multi-center cohort), 95% diagnostic accuracy (Cleveland Clinic prospective/retrospective evaluation, 100-patient cohort), and favorable cost-benefit metrics (1.1 OR ratio, 1.4 EndoSuite ratio in community hospital settings). The Galaxy System is intended for real-time imaging-guided bronchoscopic diagnosis and tissue sampling in patients with suspected lung malignancy or other pulmonary pathology. Noah Medical serves hospital systems and ambulatory surgical centers across the United States, supporting both diagnostic yield optimization and operational efficiency.

TTI Medical, established in 1984, designs and manufactures high-quality surgical instruments and medical devices, with specialization in video and digital camera adaptation systems. The company serves ophthalmology, surgical microscopy, and endoscopy markets by providing optical coupling solutions that integrate modern imaging technology with existing clinical equipment. Primary product lines include C-mount video adapters for surgical microscopes and slit lamps, digital camera adapters, endoscope couplers with 4K optical performance, CO₂ laser accessories (micromanipulators, handpieces, laparoscope couplers), fiberoptic handpieces for contact laser procedures, reusable suction/irrigation instruments for minimally invasive surgery, and medical-grade video camera systems (including the Ikegami MKC-X800 Native 4K). TTI Medical is an authorized distributor of Ikegami, Sony, and Jena Surgical products. All products are manufactured in the USA and are reusable and sterilizable. The company holds FDA registration, CE mark approval, and ISO 13485:2016 certification. TTI Medical also provides OEM solutions including custom engineering, private labeling, and laser engraving services.

Designs For Vision, Inc. is a precision optical manufacturer specializing in ergonomically designed magnification and LED illumination systems for healthcare professionals and individuals with low vision. Founded in 1961 by William Feinbloom, OD, PhD, the company operates from a 67,500 sq ft facility in Bohemia, New York, with approximately 99–123 employees and annual revenue of $14.8–14.9 million. The company manufactures custom surgical and dental telescopes with integrated LED headlight systems, high-definition imaging (HDi) devices, and advanced fluorescence-guided visualization tools (REVEAL technology for dentistry and REVEAL FC for wound imaging). Product lines include world-renowned dental loupes and surgical loupes with modular LED headlights, compact HD video recording systems, and innovative optical aids for visual rehabilitation. Designs For Vision is recognized as a pioneer in headborne surgical illumination and custom optical lens design, serving dental professionals, surgeons, and the low-vision community with a strong emphasis on customization, ergonomic design, and customer service.

iCare is a leading ophthalmic diagnostics and screening company specializing in handheld and automated devices for detection and monitoring of glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD). The company manufactures a comprehensive product line including rebound tonometers (IOP measurement devices), confocal fundus imaging systems with TrueColor technology, automated perimetry systems with active retinal tracking, and microperimetry devices. iCare's product portfolio includes the iCare IC200 handheld tonometer (market leader in rebound tonometry with validation from over 300 clinical studies), iCare EIDON Family confocal imaging systems offering ultra-high-quality detail-rich images from posterior pole to periphery, iCare COMPASS automated perimeter combining visual field testing with retinal tracking and non-mydriatic imaging, iCare MAIA microperimetry system for mesopic confocal analysis, iCare ST500 slit lamp tonometer, and iCare ILLUME screening solution featuring AI-assisted automated imaging and processing for early detection of retinal diseases. The company also offers iCare Screening Solution, a fully automated AI-assisted system for preventive eye care. All devices are designed for ease of use with minimal training, non-mydriatic capability, and intuitive interfaces. iCare is part of the Revenio Group, which includes Icare Finland Oy, Icare USA Inc., iCare World Australia, China iCare Medical Technology, Thirona RetinaB.V., and Centervue S.P.A. The company serves ophthalmologists, optometrists, general practitioners, and diabetic clinics globally. Clinical evidence and regulatory compliance underpin all product development.

GlobalMed Holdings is a leading virtual health software and hardware platform company delivering enterprise telemedicine solutions for 20+ years. The company provides eNcounter®, a comprehensive all-in-one virtual care platform supporting 55+ clinical modalities with multi-modal device integration, AI-powered triage, and true EHR/EMR interoperability. GlobalMed's hardware ecosystem includes FDA-cleared diagnostic devices—TotalExam® 3.2 Camera for high-definition remote examinations, TotalECG® for cardiac monitoring, TotalVitals® for continuous vital signs capture, and ClearProbe® ultrasound system—enabling comprehensive head-to-toe remote physical exams with diagnostic-quality imaging and real-time data streaming. The company also manufactures portable clinical delivery stations (ClinicalAccess® Pro Connect, Transportable Exam Backpack) certified to ISO 13485 for hospital-grade care in austere, remote, and emergency environments. Additional offerings include GlobalMed Wellness employee mental health apps (Moodhacker®, Love Every Day®, Family Huddle®) developed with NIH grant funding. The platform is deployed across federal agencies (DoD, VA, DHS, Department of Justice), rural health systems, correctional facilities, large health systems, and international markets across 60+ countries, supporting 100 million+ virtual healthcare visits. Certifications include SOC 2 Type II, HIPAA compliance, FDA 510(k) clearances for medical devices, ISO 13485, and Authority to Operate (ATO) on DoD networks.

AliveDx is a Swiss-based in-vitro diagnostics company with over 30 years of experience specializing in innovative solutions for autoimmune diseases, allergies, immunohematology, and disease screening. Operating from headquarters in Eysins, Switzerland, with significant facilities in the UK (Scotland) and offices across the US, UAE, and other regions, AliveDx employs approximately 500 personnel. The company has transitioned from public to private ownership while maintaining its commitment to advancing clinical diagnostics globally. AliveDx offers three primary product lines: MosaiQ®, a fully automated microarray platform enabling simultaneous complex multiplex testing with fast time-to-diagnosis; LumiQ®, an all-in-one immunofluorescence (IFA) automation solution providing turnkey workflow integration; and Alba, a comprehensive manual blood typing and immunohematology reagent portfolio. These solutions are designed to optimize laboratory workflows, enhance productivity, and deliver clinical and economic value in diagnostic settings. The company has achieved multiple regulatory milestones and maintains Great Place to Work certification, underscoring its commitment to innovation and organizational excellence in clinical diagnostics.

WoundVision is a healthcare technology company specializing in advanced wound imaging and documentation solutions. The company leverages multi-modal imaging technology, combining long-wave infrared thermography with high-resolution photography, to enhance detection of deep tissue pressure injuries and standardize wound assessment workflows. WoundVision's Scout™ Device captures simultaneous thermographic and photographic images for objective skin temperature measurement and accurate wound sizing (96% accurate versus paper rulers). The Scout Software platform provides HIPAA-compliant, enterprise-grade wound documentation with seamless EMR integration, reducing documentation errors and standardizing assessment protocols across healthcare facilities. The Scout Mobile App extends wound photography and assessment capabilities to multiple care settings. Designed for trained healthcare professionals managing diverse wound types and pressure injury prevention, WoundVision serves healthcare providers ranging from large health systems to rural hospitals and maintains contracted supplier status with HealthTrust Purchasing Group.

UE LifeSciences Inc. is a medical device innovator focused on accessible, hand-held diagnostic solutions for early cancer detection in resource-limited and low-income settings. The company develops non-invasive, radiation-free, pain-free screening devices operable by community health workers with minimal training and offline capability, enabling instant results with validated high efficacy. Their product portfolio addresses breast, cervical, and oral cancer screening—the leading cancer burdens in underserved populations globally. iBreastExam is an extensively validated handheld breast lump detection device; cervAIcal is a mobile colposcope for cervical cancer assessment; OrCA addresses oral cancer screening. RaKSA is a multi-cancer screening navigation initiative integrating breast, cervical, and oral examination into single-visit protocols for large-scale implementation. The company has supplied over 2 million breast exams, detected 500+ cancers, and operates in 10 markets across USA, India, Malaysia, Colombia, and Thailand. UE LifeSciences partners with HLL Lifecare (India), major imaging-diagnostics firms, and regional pharma and diagnostics distributors. The company has raised $8.5M in capital, secured $1.7M+ in grants, and earned 15+ awards. Featured in The New York Times, BBC News, Forbes, and TED Talks, UE LifeSciences targets primary and secondary care providers, government health programs, NGOs, and private healthcare networks seeking equitable early detection infrastructure.

THD America, Inc. is a global healthcare company specializing in innovative diagnostic and surgical solutions for anorectal disorders. The company develops and markets a comprehensive product range for the advanced diagnosis and treatment of common colorectal conditions, including hemorrhoids, anal warts, anal intraepithelial neoplasia (AIN), and anal cancer. THD offers both diagnostic procedures utilizing high-resolution anoscopy technology and minimally invasive surgical treatments. The company provides clinical evidence through published scientific studies and maintains active engagement with healthcare professionals through symposia, training programs, and participation in major colorectal surgery conferences such as the ASCRS Annual Scientific Meeting. THD's product portfolio addresses the clinical needs of proctologists and colorectal surgeons seeking advanced, less invasive treatment options for anorectal pathology.

RG Medical USA manufactures endoscopic instrumentation and robotic surgical navigation systems for minimally invasive urology and ENT procedures. Core product portfolio includes the Robotic Navigation Genius—a multifunctional robotic platform compatible with endoscopes, instruments, microscopes, and navigation systems for precision-guided surgical applications. The company also produces endoscopic instruments including the Morcescope Universal (available in 19/22, 22/24, and 24/26 Fr sizes) and the Duo Mono-Bipolar system for bipolar saline resection procedures (22/24 and 24/26 Fr). Products are designed for transurethral resection and other minimally invasive endoscopic procedures. RG Medical maintains multilingual customer support (English, Spanish, German) and operates from a US location with international distribution capabilities. The company positions itself in the premium surgical instrumentation and robotic navigation segment, serving hospitals and surgical centers performing advanced urological and endoscopic procedures.

JosNoe Medical, Inc. is a designer and manufacturer of high-quality laparoscopic and endoscopic surgical disposables. The company specializes in innovative products that enhance surgical outcomes, including anti-fog scope warmers for maintaining clear visual fields during procedures, insufflation filtered tubing sets for safe and effective gas delivery, gamma probe covers for nuclear medicine applications, and LumaGuard lightshields for patient protection. JosNoe emphasizes best-in-class design and quality control, regulatory compliance, and DEHP-free formulations across their product portfolio. The company serves hospitals, surgical centers, and medical device distributors, offering both standard products and custom OEM manufacturing services tailored to specific clinical requirements.

Advanced Monitors Corporation manufactures state-of-the-art diagnostic devices for medical professionals, veterinarians, and pet owners. The company specializes in video otoscopes (wired and wireless models compatible with phones, tablets, and computers), flexible endoscopes including gastroscopes, veterinary thermometers (instant ear and rapid rectal models), dental cameras, and surgical diode lasers. Products serve small animal veterinarians, equine veterinarians, human medical professionals, and consumer/home-use markets. The company partners with industry professionals in device design and manufacturing. Products are employed in clinical practice, emergency/critical care settings, and field/ambulatory veterinary medicine. The company sponsors professional veterinary training programs (VetPD) and maintains a video tutorial resource center for endoscopy training. Customer testimonials indicate strong adoption in veterinary intensive care units, equine diagnostic practices, and small animal ambulatory services. Manufacturing and distribution capabilities support both professional medical and veterinary markets across North America and internationally (evidenced by customer base in Germany).

Clear Guide Medical develops augmented reality (AR) and artificial intelligence (AI) guided procedural imaging software compatible with MRI, CT, and ultrasound systems. The company's core platform, SCENERGY, enables real-time image guidance for minimally invasive interventional procedures including biopsies, ablations, and other needle-based therapies. SCENERGY enhances procedural accuracy, reduces intermediate imaging steps, and improves workflow efficiency while decreasing complications and adjacent tissue damage. The platform includes SCENERGY-TP (tissue penetration variant), SCENERGY Navigation for enhanced spatial mapping, SCENERGY Fusion for multi-modality registration, and proprietary tracking solutions (VisiMARKERS and TipTAGs) that enhance needle and instrument visualization. The technology has been validated in clinical settings at Johns Hopkins Hospital and Mount Sinai Beth Israel, with peer-reviewed publications demonstrating improved confidence, speed, and accuracy for both novice and experienced operators. Products are FDA-cleared and designed for integration into existing hospital imaging workflows. Clear Guide serves hospitals, clinics, and academic medical centers, offering research partnerships and institutional licensing. The company provides technical support, user manuals, and training resources.

Sunoptic Technologies, LLC is a Jacksonville, Florida-based surgical lighting and visualization equipment manufacturer with over 45 years of industry experience. The company designs, manufactures, and distributes portable and wireless surgical headlights, high-definition surgical camera systems, xenon light sources, LED light sources, fiberoptic cables, and illuminated retractor systems. All products are designed and manufactured in-house at their Jacksonville headquarters facility. Primary product lines include LED headlight systems (SSL-LX2, SSL-9500, SSL-4700, SSL-5500), xenon light sources (TITAN X400 at 400 watts, TITAN X300, Pro300), LED light sources (LED 4500, LED 2000), fiberoptic headlight systems for both xenon and LED sources, HD surgical camera systems (HDC-300 with coaxial stabilization, SSL-LHD-30 wireless), and TracLux illuminated retractor and lighting products (HandLite, LiteClip, Rover). The company serves neurosurgery, spine, cardiac, vascular, endoscopic, ENT, general surgery, maxillofacial, oncology, pediatric, plastics, transplant, ASC, and dental specialties. Sunoptic holds ISO 13485 certification and is an approved vendor with Premier, HealthTrust, AHP, and Vizient group purchasing organizations. Products feature ergonomic designs with emphasis on surgeon comfort, lightweight construction, rechargeable battery options with extended run times, and wireless capabilities. The company maintains continuous R&D investment and provides flexible financing and trial programs for qualified customers.

Cook Medical is a global manufacturer of minimally invasive medical devices across multiple specialties including cardiology, urology, gastroenterology, otolaryngology, and vascular intervention. The company designs, manufactures, and distributes a broad portfolio of devices for endoscopic procedures, catheterization labs, peripheral and thoracic vascular intervention, and urological applications. Key product lines include endoscopic hemostasis devices (Hemospray®), esophageal balloons (Hercules® 100), microcatheters (Cantata®), ureteral stents (Resonance® Metallic Ureteral Stent Set), endovascular grafts (Zenith Alpha™), and drug-eluting peripheral stents (Zilver® PTX®). The company operates customer portals, maintains comprehensive Instructions for Use databases, and provides formal education and training programs (Vista® Education & Training). Cook Medical serves healthcare systems globally with FDA-cleared and CE-marked devices for minimally invasive therapeutic and interventional procedures. The organization supports MRI-safe device documentation and maintains active regulatory compliance across US and international markets.

Diversatek Healthcare is a GI-focused medical device and diagnostic systems manufacturer with over 40 years of partnership history with gastroenterology providers. The company designs and distributes diagnostic testing systems and therapeutic devices for ambulatory surgery centers, physician offices, and hospitals across the U.S. and internationally. Primary product lines include esophageal and anorectal manometry systems, reflux diagnostic testing (impedance/pH), and endoscopic therapeutic devices. Flagship diagnostics include the MiVu™ Mucosal Integrity Testing System for real-time differentiation of GERD, EoE, and Non-GERD during routine endoscopy. Therapeutic devices include the Replay® Hemostasis Clip (removable, fully rotatable) and SafeGuide® Single OTW Esophageal Dilators with depth and French size markings. Diversatek operates a training center in Highlands Ranch, Colorado, offering on-site clinical education, hands-on manometry training, and software proficiency instruction. The company also provides comprehensive clinical support, technical support, and customer service for diagnostic equipment operation, maintenance, and data interpretation.

Avatar Medical USA Inc develops FDA-cleared and CE-marked 3D medical imaging visualization software that transforms DICOM medical images into interactive 3D patient avatars for clinical consultation, surgical planning, and medical education. The platform is hardware-agnostic and integrates with existing PACS systems without preprocessing requirements. It enables real-time 3D visualization suitable for multiple surgical specialties including neurosurgery, oncology, ENT, oral maxillofacial surgery, cardiovascular and vascular surgery, and urology. The software supports intraoperative guidance, multidisciplinary team collaboration, and patient engagement during pre- and post-operative consultations. Avatar Medical also offers Eonis Vision, a consultation-focused product, and Avatar Medical Academy for medical education. The platform supports extended reality (XR) interaction for immersive visualization. Clinical applications span from patient communication and informed consent to detailed surgical planning and training environments. The company serves major teaching hospitals and medical centers across North America and Europe, including Assistance Publique-Hôpitaux de Paris, Sorbonne University, and University of Miami.

Gentuity, LLC is a medical device manufacturer specializing in next-generation intravascular imaging solutions for interventional cardiology. The company's core product is the HF-OCT™ Imaging System, a high-frequency optical coherence tomography platform designed for percutaneous coronary intervention (PCI) guidance and coronary artery disease assessment. The system integrates with the Vis-Rx® PRIME Micro-Imaging Catheter, an ultra-low-profile (1.8F) device enabling access to small, tortuous, and complex coronary vessels. Key clinical capabilities include rapid full-length vessel imaging in a single pullback, saline-compatible imaging, and real-time visualization for procedural optimization. The HF-OCT system features plug-and-play integration into catheterization laboratory workflows without requiring sterile barriers. Gentuity's products target interventional cardiologists performing complex PCI procedures, with distribution partnerships including GE HealthCare (United States), Nipro Medical Europe (EMEA), and Nipro Japan. The company holds regulatory clearance documentation including Summary of Safety and Clinical Performance (SSCP) and maintains DICOM conformance standards. Marketing emphasizes clinical case studies demonstrating utility in challenging anatomies, including critically narrow lesions and calcified vessels. The company actively participates in major interventional cardiology conferences (TCT, EuroPCR, SCAI) and publishes peer-reviewed clinical evidence.

MetaOptima Technology Inc. is a dermatology-focused medical technology company specializing in intelligent skin imaging and analytics platforms. The company develops AI-powered solutions for skin cancer detection, melanoma screening, and dermatological documentation. Its primary product offerings include OptimaScan, a mobile 3D total body photography system capable of full-body imaging in under one minute with 360° rotating arm capture and 48MP resolution, integrated with AI analysis; DermEngine, an advanced cloud-based platform for skin imaging, analytics, and clinical documentation used by medical professionals globally; and MoleScope, a patient-facing skin imaging device with smartphone integration for personal skin monitoring. MetaOptima's technology leverages artificial intelligence for enhanced diagnostic accuracy and workflow efficiency in dermatology practices, surgical centers, and skin cancer screening programs. The company serves dermatologists, surgical centers, melanoma diagnostic centers, and healthcare networks across Australia, New Zealand, Canada, and internationally. Products integrate seamlessly across the company's ecosystem, enabling standardized documentation, longitudinal tracking, and AI-assisted analysis. MetaOptima has demonstrated partnerships with major healthcare organizations, research institutions, and consumer health brands including L'Oréal, La Roche-Posay, Sonic Healthcare, and Melanoma Institute Australia. The company participates in government innovation programs and attends major international medical conferences including MEDICA and EADV Congress, indicating regulatory engagement and clinical validation efforts.

GeoTec, Inc. is a full-service contract manufacturer of custom medical devices and instruments, founded in 1983 and headquartered in Warwick, Rhode Island. The company specializes in design, development, prototyping, and manufacturing across diverse medical disciplines. Core capabilities include surgical instruments (conception through manufacturing, clinical trial support, process development), custom OEM and top-assembly manufacturing with full traceability, imaging optics and light delivery systems (rod lens systems, flexible imaging systems, video microscopes), and sterilization services (ethylene oxide and gamma sterilization). GeoTec provides comprehensive support from concept to finished product, emphasizing reliable and repeatable manufacturing processes. Additional services include package testing, small lens testing, custom testing with accelerated aging protocols, and custom packaging solutions (pouch sealing, tray sealing, labeling, boxing, shrink wrapping). The company maintains ISO and FDA compliance throughout its operations, with focus on GMP-approved sterilization and regulatory-compliant manufacturing. GeoTec serves medical device manufacturers, OEMs, and healthcare companies requiring contract manufacturing, design validation, clinical trial production, and sterilization expertise.

Joimax GmbH is a global leader in endoscopic minimally invasive spine surgery, with 25 years of expertise in innovative surgical solutions and technologies. The company designs and manufactures a comprehensive portfolio of endoscopic systems and instruments for transforaminal, interlaminar, and cervical spinal procedures. Their product lines include the TESSYS endoscope system for transforaminal access, the iLESSYS endoscope, the CAMsource Duo camera system for high-definition visualization, and the Shrill Spinner Blades for efficient discectomy in fusion procedures. Joimax systems support open, minimally invasive, and fully endoscopic surgical techniques. The company maintains a strong commitment to surgeon education and training, offering comprehensive certification programs and technical support worldwide. Joimax instruments and systems are designed to prioritize patient outcomes through reduced tissue trauma and accelerated recovery. As a medical device manufacturer serving spine centers, orthopedic hospitals, and ambulatory surgery centers globally, the company provides integrated surgical platforms that combine advanced visualization, specialized instrumentation, and procedural guidance for endoscopic spine interventions.

Biocare Medical is a clinical pathology company specializing in immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH) solutions for diagnostic and research laboratories. The company designs and manufactures an integrated platform of advanced staining instruments and over 300 optimized antibodies. Core product lines include the NeoPATH Pro, ONCORE Pro X, intelliPATH+, and intelliPATH MAX staining instruments, complemented by proprietary detection systems (MACH 4, MACH 3, MACH 2, MACH 1), multiplex IHC detection kits, and ancillary reagents (antigen retrieval solutions, enzymes, blocking reagents, mounting media, and wash buffers). The company also offers primary antibodies for various tissue types, FISH probes with copy control capabilities, RISH (RNA in situ hybridization) products, and animal tissue detection systems (PromARK). Biocare serves 50+ countries and maintains placements in over 1,000 clinical laboratories, including 95% of the top 50 cancer centers in the US. The company holds ISO 13485 certification and IVDR (In Vitro Diagnostic Regulation) certification for European markets. Technical support is available 24/7; customer service operates 6:30 AM–5:00 PM PST. Biocare was acquired by Agilent in 2024.

MediView XR, Inc. is a clinical augmented reality med-tech company specializing in first-in-class AR-powered visualization and navigation solutions for image-guided surgical and interventional procedures. The company develops mixed-reality platforms that overlay real-time 3D anatomical data, live ultrasound imaging, and procedural guidance directly into the surgeon's field of view via holographic heads-up displays. MediView's flagship products—OmnifyXR® Interventional Suite and XR90™ Holographic Surgical Navigation System—enable minimally invasive, ultrasound-guided soft tissue and bone procedures with improved ergonomics, workflow efficiency, spatial visualization depth, and real-time collaborative remote consultation and proctoring capabilities. The XR90 is FDA 510(k)-cleared and integrates seamlessly with GE HealthCare's Allia interventional imaging platform. Primary markets include interventional radiology, minimally invasive surgery, orthopedic surgery, and urological procedures. The company partners with leading academic medical centers and hospitals including The Cleveland Clinic, Mayo Clinic, NewYork Presbyterian/Weill Cornell Medicine, Memorial Sloan Kettering, and Ohio State University. MediView is Microsoft Gold partner and member of the American Medical Extended Reality Association. Recent Series A funding of $24M was led by GE HealthCare, Mayo Clinic, and Cleveland Clinic.